学术探索
学术期刊
新闻热点
数据分析
智能评审

THE WOMAN AT INCREASED RISK FOR BREAST-CANCER - EVALUATION AND MANAGEMENT STRATEGIES

被引：68
作者：
BILIMORIA, MM
MORROW, M
机构：
[1] Department of Surgery, Northwestern University Medical School, Chicago, Illinois
[2] Lynn Sage Comprehensive Breast Center, Northwestern University Medical School in Chicago, Illinois
来源：
CA-A CANCER JOURNAL FOR CLINICIANS | 1995年 / 45卷 / 05期
关键词：
D O I：
10.3322/canjclin.45.5.263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Increased understanding of risk factors for breast cancer, especially the identification of genes associated with a predisposition to breast cancer, has focused attention on the issue of breast cancer prevention. At present, the only clinically available method of breast cancer prevention is prophylactic mastectomy. However, there are no absolute indications for its use, and it is not often appropriate in relation to actual risk for disease. This article reviews what is known about major breast cancer risk factors, reviews the available data on prophylactic mastectomy, and discusses current strategies for the management of the woman at increased risk for breast cancer.
引用
收藏
页码：263 / 278
页数：16
相关论文
共 80 条
  • [1] Harris JR, Morrow M, Bonadonna G, Cancer of the Breast, Cancer Principles and Practice of Oncology, pp. 1264-1332, (1993)
  • [2] Seidman H, Mushinski MH, Gelb SK, Silverberg E, Probabilities of eventually developing or dying of cancer: United States, 1985, CA Cancer J Clin, 35, pp. 36-56, (1985)
  • [3] Jordan VG, Morrow M, An appraisal of strategies to reduce the incidence of breast cancer, Stem Cells, 11, pp. 252-262, (1993)
  • [4] Newman B, Austin MA, Lee M, King MC, Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high risk families, Proc Natl Acad Sci U S A, 85, pp. 3044-3048, (1988)
  • [5] Claus EB, Risch N, Thompson WD, Genetic analysis of breast cancer in the cancer and steroid hormone study, Am J Hum Genet, 48, pp. 232-242, (1991)
  • [6] Malkin D, Li FP, Strong LC, Et al., Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, 250, pp. 1233-1238, (1990)
  • [7] Sidransky D, Tokino T, Helzlsouer K, Et al., Inherited p53 gene mutations in breast cancer, Cancer Res, 52, pp. 2984-2986, (1992)
  • [8] Coles C, Condie A, Chetty U, Et al., p53 mutations in breast cancer, Cancer Res, 52, pp. 5291-5298, (1992)
  • [9] Smith SA, Easton DF, Evans DG, Ponder BA, Allele losses in the region 17q 12–21 in familial breast cancer and ovarian cancer involve the wild‐type chromosome, Nat Genet, 2, pp. 128-131, (1992)
  • [10] Miki Y, Swensen J, Shattuck-Eidens D, Et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, 266, pp. 66-71, (1994)
12345678